Literature DB >> 3103092

Discounting an adverse maternal effect on severity of neurofibromatosis.

V M Riccardi, J S Wald.   

Abstract

Neurofibromatosis, a common, progressive, autosomal dominant disorder, is markedly variable in its expressivity. Some authors have suggested that some contribution to neurofibromatosis's variability may be an adverse effect of a mother's neurofibromatosis on the overall severity seen in her offspring with neurofibromatosis. In the present study of 188 maternal affected, paternal affected, and sporadic von Recklinghausen neurofibromatosis cases, the maternal influence question was systematically examined. Overall severity, selected features most likely to reflect in utero maternal influence, and other common neurofibromatosis-I features were analyzed statistically. Age, racial composition, and gender of the three groups were similar. No significant differences were found (P less than or equal to .01) between maternal affected, paternal affected, and sporadic cases in terms of overall severity, probability of reaching advanced severity as a function of age, indications of possible prenatal influence (eg, congenital neurofibromas, tibial pseudarthrosis), or other neurofibromatosis features. These results demonstrate that the nature and severity of neurofibromatosis for maternal affected cases are essentially the same as for paternal affected and sporadic cases.

Entities:  

Mesh:

Year:  1987        PMID: 3103092

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity.

Authors:  S M Huson; D A Compston; P Clark; P S Harper
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

Review 2.  Clinical and genetic patterns of neurofibromatosis 1 and 2.

Authors:  N K Ragge
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

3.  Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas.

Authors:  K J Johnson; M J Fisher; R L Listernick; K N North; E K Schorry; D Viskochil; M Weinstein; J B Rubin; D H Gutmann
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

4.  Neurofibromatosis type 1 in children.

Authors:  G R Beauchamp
Journal:  Trans Am Ophthalmol Soc       Date:  1995

5.  Different patterns of mast cells distinguish diffuse from encapsulated neurofibromas in patients with neurofibromatosis 1.

Authors:  Tracy Tucker; Vincent M Riccardi; Margaret Sutcliffe; Juergen Vielkind; Janine Wechsler; Pierre Wolkenstein; Jan M Friedman
Journal:  J Histochem Cytochem       Date:  2011-04-27       Impact factor: 2.479

6.  Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?

Authors:  Claudia Santoro; Pia Bernardo; Antonietta Coppola; Umberto Pugliese; Mario Cirillo; Teresa Giugliano; Giulio Piluso; Giuseppe Cinalli; Salvatore Striano; Carmela Bravaccio; Silverio Perrotta
Journal:  Ital J Pediatr       Date:  2018-03-22       Impact factor: 2.638

7.  Predictive Modeling for Clinical Features Associated With Neurofibromatosis Type 1.

Authors:  Stephanie M Morris; Aditi Gupta; Seunghwan Kim; Randi E Foraker; David H Gutmann; Philip R O Payne
Journal:  Neurol Clin Pract       Date:  2021-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.